rosiglitazone has been researched along with fluorescein-5-isothiocyanate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angeli, V; Capron, M; Hammad, H; Lambrecht, BN; Staels, B; Trottein, F | 1 |
| Badgeley, MA; Bagalkot, V; Deiuliis, JA; Kampfrath, T; Maiseyeu, A; Rajagopalan, S | 1 |
2 other study(ies) available for rosiglitazone and fluorescein-5-isothiocyanate
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor gamma inhibits the migration of dendritic cells: consequences for the immune response.
Topics: Animals; Cell Migration Inhibition; Cell Movement; Cells, Cultured; Cytokines; Dendritic Cells; Dermatitis, Contact; Epidermis; Female; Fluorescein-5-isothiocyanate; Haptens; Immunosuppressive Agents; Langerhans Cells; Lung; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Transgenic; Ovalbumin; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Thorax; Transcription Factors; Transcriptional Activation; Tumor Necrosis Factor-alpha | 2003 |
Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals.
Topics: Animals; Anti-Inflammatory Agents; Apolipoproteins E; Atherosclerosis; Cell Line; Cholesterol; Cytokines; Fluorescein-5-isothiocyanate; Gadolinium; Macrophages; Mice, Inbred C57BL; Mice, Knockout; Nanoparticles; Obesity; Paclitaxel; Phagocytosis; Phosphatidylethanolamines; Phosphatidylserines; Phospholipases A2; Polyethylene Glycols; Polystyrenes; Rosiglitazone; Tamoxifen; Thiazolidinediones | 2015 |